Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Official Publications
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Official Publications
04/30/21Monthly statement on outstanding equity shares and voting rights 
04/30/21Proxy Statments 
04/30/21Proxy Statments 
04/28/211st quarter earnings 
04/28/211st quarter earnings 
04/16/21Acquisition 
04/16/21Mixed general Shareholders meeting notice 
04/12/21Mixed general Shareholders meeting notice 
04/09/21Acquisition 
03/31/21Monthly statement on outstanding equity shares and voting rights 
03/31/21Monthly statement on outstanding equity shares and voting rights 
03/04/21Report 
03/03/21Nomination 
02/28/21Monthly statement on outstanding equity shares and voting rights 
02/28/21Monthly statement on outstanding equity shares and voting rights 
02/05/21Press Release 
02/05/21Annual results 
02/05/21Annual results 
01/31/21Monthly statement on outstanding equity shares and voting rights 
01/31/21Monthly statement on outstanding equity shares and voting rights 
01/12/21Nomination 
01/12/21Nomination 
12/31/20Monthly statement on outstanding equity shares and voting rights 
12/31/20Monthly statement on outstanding equity shares and voting rights 
11/30/20Monthly statement on outstanding equity shares and voting rights 
11/30/20Monthly statement on outstanding equity shares and voting rights 
11/20/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
11/13/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
10/31/20Monthly statement on outstanding equity shares and voting rights 
10/31/20Monthly statement on outstanding equity shares and voting rights 
10/29/20Press Release 
10/29/203rd quarter results 
10/29/203rd quarter results 
09/30/20Monthly statement on outstanding equity shares and voting rights 
09/30/20Monthly statement on outstanding equity shares and voting rights 
09/28/20Acquisition 
08/31/20Monthly statement on outstanding equity shares and voting rights 
08/31/20Monthly statement on outstanding equity shares and voting rights 
07/31/20Monthly statement on outstanding equity shares and voting rights 
07/31/20Monthly statement on outstanding equity shares and voting rights 
07/29/20Press Release 
07/29/202nd quarter earnings 
06/30/20Half-year report 
06/30/20Half-year report 
06/30/20Monthly statement on outstanding equity shares and voting rights 
06/30/20Monthly statement on outstanding equity shares and voting rights 
05/31/20Monthly statement on outstanding equity shares and voting rights 
05/31/20Monthly statement on outstanding equity shares and voting rights 
05/26/20Crossing thresholds 
04/28/20Press Release 
04/28/20Proxy Statments 
04/28/20Proxy Statments 
04/24/20Press Release 
04/24/201st quarter earnings 
04/22/20Crossing thresholds 
04/08/20Ordinary general Shareholders meeting notice 
04/03/20Mixed general Shareholders meeting notice 
03/13/20Ordinary general Shareholders meeting 
03/11/20Balo 
02/06/20Press Release 
02/06/20Annual results 
02/06/20Annual results 
01/31/20Monthly statement on outstanding equity shares and voting rights 
01/31/20Monthly statement on outstanding equity shares and voting rights 
12/31/19Report 
12/31/19Report 
12/31/19Institutional report 
12/31/19Report 
12/31/19SEC Filing 20 F 
12/31/19Monthly statement on outstanding equity shares and voting rights 
12/31/19Monthly statement on outstanding equity shares and voting rights 
12/13/19Corporate Officers and Executives' transactions in the company's securities - Purchase 
11/24/19Corporate Officers and Executives' transactions in the company's securities - Purchase 
10/31/193rd quarter results 
10/31/19Press Release 
1  2Next
Analysis
Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - executive
Stock Pick
 SANOFI
At a crossroads
Stock Trading Strategies
TRADING
 No turn-around in sight
Official Publications
04/30Monthly statement on outstanding equity sh.. 
04/30Proxy Statments 
04/30Proxy Statments 
04/281st quarter earnings 
04/281st quarter earnings 
04/16Acquisition 
Upcoming event on SANOFI
10/28/21
Upcoming sector events
08/03/21ELI LILLY AND COMPANY :
10/19/21JOHNSON & JOHNSON :
10/26/21ELI LILLY AND COMPANY :
10/26/21NOVARTIS AG :
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals